Researchers Develop Genetic Test To Help Identify Patients With Cancer At Highest Risk For Complication From Treatment With Bevacizumab

Medscape (10/30, Osterweil, Subscription Publication) reported, “Up to 40% of patients with cancer who are treated with bevacizumab develop severe hypertension and renal toxicity,” but researchers have developed a “genetic test performed before treatment”...